LeMaitre Vascular Inc  

(Public, NASDAQ:LMAT)   Watch this stock  
Find more results for Pruitt
7.99
0.00 (0.00%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.96 - 8.04
52 week 5.97 - 8.96
Open 7.96
Vol / Avg. 10,214.00/11,817.00
Mkt cap 124.48M
P/E 39.32
Div/yield 0.04/1.75
EPS 0.20
Shares 15.58M
Beta 0.10
Inst. own 36%
Apr 29, 2014
Q1 2014 LeMaitre Vascular, Inc. Earnings Conference Call - 5:00PM EDT - Add to calendar
Apr 29, 2014
Q1 2014 LeMaitre Vascular, Inc. Earnings Release - 4:00PM EDT - Add to calendar
Apr 9, 2014
LeMaitre Vascular, Inc. at Needham Healthcare Conference
Mar 10, 2014
LeMaitre Vascular, Inc. at ROTH Conference
Feb 25, 2014
Q4 2013 LeMaitre Vascular, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 4.16% 4.96%
Operating margin 6.54% 7.00%
EBITD margin - 11.33%
Return on average assets 4.37% 4.80%
Return on average equity 5.35% 5.85%
Employees 328 -
CDP Score - -

Address

63 2ND AVE
BURLINGTON, MA 1803
United States - Map
+1-781-2212266 (Phone)
+1-781-4255049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LeMaitre Vascular, Inc. (LeMaitre Vascular) is a global provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufacture, and market vascular devices to addresses the needs of vascular surgeons. The Company's diversified portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and are well known to vascular surgeons, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, and VascuTape Radiopaque Tape. The Company sells 12 product lines, most of which are used in open vascular surgery and some of which are used in endovascular procedures. The Company sells its products primarily through a direct sales force. The Company´┐Żs products are used by vascular surgeons who treat peripheral vascular disease through both open surgical methods and endovascular techniques. In August 2013, Lemaitre Vascular Inc acquired the assets of InaVein, LLC.

Officers and directors

George W. LeMaitre Chairman of the Board, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Roberts President, Director
Age: 49
Bio & Compensation  - Reuters
Joseph P. Pellegrino Jr. Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Peter R. Gebauer President - International Operations
Age: 59
Bio & Compensation  - Reuters
Robert V. Linden Senior Vice President - Sales, The Americas
Age: 46
Bio & Compensation  - Reuters
Trent G. Kamke Senior Vice President - Operations
Age: 42
Bio & Compensation  - Reuters
Maik D. Helmers Vice President - Sales, Central Europe
Age: 39
Bio & Compensation  - Reuters
Kimberly L. Cieslak Vice President - Marketing
Age: 40
Bio & Compensation  - Reuters
Wolfgang Meichelboeck Vice President - Marketing International
Age: 56
Bio & Compensation  - Reuters
Cornelia W. LeMaitre Vice President - Human Resources, Director
Age: 77
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance